Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"

Перейти
на сайт
журнала
"Врач"
Перейти на сайт журнала "Медицинская сестра"
Перейти на сайт журнала "Фармация"
Перейти на сайт журнала "Молекулярная медицина"
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
Журнал включен в российские и международные библиотечные и реферативные базы данных

ВАК (Россия)
РИНЦ (Россия)
Эко-Вектор (Россия)

SYNTHESIS, ANTIAGGREGANT AND ANTICOAGULANT ACTIVITY OF 2-[3-METHYL-8-MORPHOLINO-7-(THIETANYL-3)XANTHINYL-1]ACETIC ACID SALTS

DOI: https://doi.org/10.29296/25877313-2020-01-04
Download full text PDF
Issue: 
1
Year: 
2020

E.E. Klen Dr.Sc. (Pharm.), Associate Professor, Department of Pharmaceutical Chemistry with courses of analytical and toxicological chemistry, Bashkir State Medical University (Ufa) E-mail: klen_elena@yahoo.com V.A. Nebogatova Postgraduate Student, Department of Pharmaceutical Chemistry with courses of analytical and toxicological chemistry, Bashkir State Medical University (Ufa) E-mail: neb-veronika@inbox.ru L.I. Bashirova Post-graduate Student, Department of General and Clinical Pharmacology, Izhevsk State Medical Academy (Izhevsk) E-mail: lindadeireko@mail.ru A.L. Urakov Dr.Sc. (Med.), professor, Head of Department of General and Clinical Pharmacology, Izhevsk State Medical Academy (Izhevsk) E-mail: urakoval@live.ru A.V. Samorodov Dr.Sc. (Med.), Associate Professor, Department of Anesthesiology and Resuscitation with the course IDPO, Bashkir State Medical University (Ufa) E-mail: avsamorodov@gmail.com F.A. Khaliullin Dr.Sc. (Pharm.), Professor, Head of Department of Pharmaceutical Chemistry with courses of analytical and toxicological chemistry, Bashkir State Med-ical University (Ufa) Email: khaliullin_ufa@yahoo.com

The purpose of the study was to develop methods for the synthesis of salts of 2-[3-methyl-8-morpholino-7-(thietanyl-3)xanthinyl-1]acetic acid, to study their effect on the hemostatic system, and to predict toxic risks and pharmacokinetic characteristics. 8-Morpholine derivative II was synthe-sized by reaction of ethyl 2-[8-bromo-3-methyl-7-(thietanyl-3)xanthinyl-1]acetate with morpholine. By hydrolysis of derivative II acid III was obtainedin good yield. Water-soluble salts IVa-g were synthesized using acid III and amines. The structure of synthesized compounds was determined by spectral methods (IR, NMR spectroscopy). According to the computer prediction salts IVa-g should not have toxic risks, most of them satisfy Lipinski's rule of five. In vitro investigation of the antiaggregant and anticoagulant activity of new substances indicated that compounds IVa,d exhibited antiaggregant activity and IVb,f  weak anticoagulant activity.
Keywords: 
thietane
morpholine
xanthinyl-1-acetic acid
antiaggregant activity
anticoagulant activity
Lipinski's rule of five

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J. Thromb. Haemost. 2014; 12:1580–1590.
  2. Chan N.C. Antithrombotic Agents New Directions in Antithrombotic Therapy. Circ. Res. 2019; 124:426426.
  3. Shanshan Huang, Yujie Ren, Xiuxiu Peng, Pingping Qian, Lingwei Meng. Computer-aid drug design, synthesis, and anticoagulant activity evaluation of novel dabigatran derivatives as thrombin inhibitors. Eur. J. Pharm. Sci. 2019; 137:104965.
  4. Debbabi M., Nimbarte V.D., Chekir S. et al. Design and synthesis of novel potent anticoagulant and anti-tyrosinasepyranopyrimidines and pyranotriazolopyrimidines: Insights from molecular docking and SAR analysis. Bioorg. Chem. 2019; 82:129138.
  5. Samorodov A.V., Kamilov F.H., Haliullin F.A. i dr. Rezul'taty doklinicheskih issledovanij novoj ciklogeksilammonievoj soli 2-[3-metil-7-(1,1-dioksotietanil-3)-1-etilksantinil-8-tio]uksusnoj kisloty v otnoshenii sistemy gemostaza v usloviyah in vivo. Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii. 2016; 8:1017.
  6. Haliullin F.A., Shabalina Yu.V., Samorodov A.V. i dr. Sintez i antiagregacionnaya aktivnost' solej 2-[3-metil-1-etilksantinil-8-tio]uksusnyh kislot, soderzhashchih tietanovyj cikl. Himiko-farmacevticheskij zhurnal. 2018; 52:2932.
  7. Urakov A.L., Samorodov A.V. Kamilov F.Kh., et al. Hemostatical activity of new benzylammonium salt 2-[3-methyl-1-n-propyl-7-(1,1-dioxotiethanyl-3)xantinyl-8-thio]acetic acid. Natl. J. Physiol. Pharm.Pharmacol. 2017; 7:12131218.
  8. Sander T., Freyss J., von Korff M., Rufener C. Data Warrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis. J. Chem. Inf. Model. 2015; 55:460473.
  9. Klen E.E., Nebogatova V.A., Haliullin F.A. Issledovanie reakcij alkilirovaniya 8-brom-3-metil-7-(tietanil-3)ksantina efirami α-galogenuksusnyh kislot. Bashkirskij himicheskij zhurnal. 2018; 25:2529.
  10. Born G.V.R. Quantitative investigation into the aggregation of blood platelets. J. Physiol. 1962; 162:67–68.
  11. Rukovodstvo po provedeniyu doklinicheskih issledovanij lekarstvennyh sredstv. CHast' pervaya. M.: GrifiK, 2012, 944 c.
  12. Lipinski C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. And Toxicol. Methods. 2000; 44:235249